Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 31, 2026 19:30 ET | Source: ASCENTAGE PHARMA GROUP INTERNATIONAL

Ascentage Pharma Presents Data on Olverembatinib in CML-LBP and Ph+ BCP-ALL at ASCO 2026

ROCKVILLE, Md. and SUZHOU, China, May 31, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical company...
May 31, 2026 19:30 ET | Source: ASCENTAGE PHARMA GROUP INTERNATIONAL

Ascentage Pharma Presents Its First Dataset on MDM2-p53 Inhibitor Alrizomadlin (APG-115) in Pediatric Solid Tumors at ASCO 2026

ROCKVILLE, Md. and SUZHOU, China, May 31, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical company...
May 31, 2026 19:30 ET | Source: ASCENTAGE PHARMA GROUP INTERNATIONAL

Ascentage Pharma Presents Updated Clinical Data for Olverembatinib as Second-Line Therapy in CML-CP at ASCO 2026

ROCKVILLE, Md. and SUZHOU, China, May 31, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical company...
May 31, 2026 14:38 ET | Source: Glyco Harmony

Glyco Harmony Drops [URGENT REPORT 2026] GlycoHarmony Shocking Complete Scientific Breakdown of Benefits Everyone Is Talking

New York City, NY, May 31, 2026 (GLOBE NEWSWIRE) -- As awareness of metabolic health continues to rise worldwide, consumers are increasingly searching for products that can help support healthy...
May 31, 2026 13:24 ET | Source: SlimTide

SlimTide Capsules [SHOCKING REPORT 2026] Slim Tide Latest Viral Weight-Loss Supplement Craze, Counterfeit Market Explosion, and Consumer Safety Concerns

Slim Tide Capsules Reviews and Complaints: SlimTide Shocking Reveal What Consumers Need to Know About the Viral Weight Loss Supplement in 2026
May 31, 2026 10:00 ET | Source: Precede Biosciences, Inc.

Precede Biosciences Presents New ASCO 2026 Data Demonstrating Ability of Precede Bio Insight™ to Decode MET-Driven Biology and Resistance in Advanced NSCLC

Data include assessment of MET expression, tumor and immune pathway activity, and lineage plasticity from just 1 mL of plasma in advanced NSCLCPlasma MET test showed high concordance with tissue...
May 31, 2026 08:00 ET | Source: Replimune, Inc.

Replimune Presents Final First-in-Human Data for RP2 in Advanced Solid Tumors During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting

WOBURN, Mass., May 31, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today...
May 30, 2026 14:30 ET | Source: Orion Oyj

Orion Pharma announces first results from Phase 1/2 TEADES trial with TEAD inhibitor ODM-212 in patients with advanced solid tumours

ORION CORPORATION PRESS RELEASE 30 MAY 2026 at 21:30 EEST Orion Pharma announces first results from Phase 1/2 TEADES trial with TEAD inhibitor ODM-212 in patients with advanced solid...
May 30, 2026 14:30 ET | Source: Orion Oyj

Orion Pharma julkisti ensimmäiset tulokset Faasi 1/2 TEADES-tutkimuksesta ODM-212-molekyylillä (TEAD-estäjä) potilailla, joilla on kiinteitä kasvaimia ja edennyt syöpä

ORION OYJ LEHDISTÖTIEDOTE 30.5.2026 KLO 21.30 Orion Pharma julkisti ensimmäiset tulokset Faasi 1/2 TEADES-tutkimuksesta ODM-212-molekyylillä (TEAD-estäjä) potilailla, joilla...
May 30, 2026 10:27 ET | Source: Vapofil

Vapofil Reviews [URGENT REPORT 2026] The Shocking VapoFil Male Enhancement Supplement Trend Everyone Is Talking About

New York City, NY, May 30, 2026 (GLOBE NEWSWIRE) -- The global men’s wellness industry continues to grow rapidly, driven by increasing consumer demand for natural alternatives that support energy,...